| 1 | Joubert syndrome 1 | Enrichment | AHI1, ARL13B, ARMC9, B9D1, B9D2, CC2D2A, CEP104, CEP290, CPLANE1, CSPP1, INPP5E, KIAA0586, MKS1, NPHP1, NPHP3, NPHP4, OFD1, PIBF1, RPGRIP1L, TCTN1, TCTN2, TCTN3, TMEM138, TMEM216, TMEM231, TMEM237, TMEM67 | 11.73 |
| 2 | Meckel syndrome, type 1 | Enrichment | B9D1, B9D2, CC2D2A, CEP290, CSPP1, KIAA0586, MKS1, RPGRIP1L, TCTN1, TCTN2, TCTN3, TMEM138, TMEM17, TMEM216, TMEM231, TMEM237, TMEM67 | 11.70 |
| 3 | Isolated joubert syndrome | Enrichment | AHI1, ARL13B, ARL3, ARMC9, B9D1, B9D2, CEP104, CEP120, CEP41, CPLANE1, CSPP1, INPP5E, KIAA0586, MKS1, OFD1, PDE6D, PIBF1, SUFU, TCTN1, TCTN2, TCTN3, TMEM237, TMEM67 | 10.90 |
| 4 | Bardet-biedl syndrome | Enrichment | BBS1, BBS2, BBS4, BBS5, BBS7, BBS9, CEP290, MKS1, NPHP1, NPHP4, RPGRIP1L, TMEM67, TTC8 | 10.77 |
| 5 | Retinitis pigmentosa | Enrichment | AHI1, ARL3, BBS1, BBS2, BBS4, BBS7, BBS9, CC2D2A, CEP290, INPP5E, KIAA0586, MKS1, NPHP4, OFD1, PDE6A, PDE6B, PDE6G, RP2, TMEM216, TTC8 | 10.73 |
| 6 | Nephronophthisis | Enrichment | AHI1, ANKS6, CEP290, CPLANE1, INVS, NPHP1, NPHP3, NPHP4 | 10.58 |
| 7 | Coach syndrome 1 | Enrichment | CC2D2A, INPP5E, OFD1, RPGRIP1L, TMEM67 | 10.55 |
| 8 | Joubert syndrome with ocular defect | Enrichment | AHI1, CEP120, CEP41, INPP5E, MKS1 | 10.55 |
| 9 | Orofaciodigital syndrome vi | Enrichment | CPLANE1, OFD1, PDE6D, TCTN3, TMEM216, TMEM231 | 10.54 |
| 10 | Arima syndrome | Enrichment | CC2D2A, CEP290, TMEM138, TMEM216, TMEM231, TMEM237, ZNF423 | 10.53 |
| 11 | Hereditary retinal dystrophy | Enrichment | AHI1, BBS1, BBS2, BBS4, BBS5, BBS7, BBS9, CC2D2A, CEP164, CEP290, INPP5E, KIAA0586, NPHP1, NPHP4, OFD1, PDE6A, PDE6B, PDE6G, RP2, TTC8 | 10.52 |
| 12 | Fundus dystrophy | Enrichment | AHI1, BBS1, BBS2, BBS4, BBS5, BBS7, BBS9, CC2D2A, CEP164, CEP290, INPP5E, KIAA0586, NPHP1, NPHP4, OFD1, PDE6A, PDE6B, PDE6G, RP2, TTC8 | 10.52 |
| 13 | Bardet-biedl syndrome 1 | Enrichment | BBS1, BBS2, BBS4, BBS5, BBS7, BBS9 | 10.31 |
| 14 | Senior-loken syndrome 1 | Enrichment | CEP164, CEP290, INVS, NPHP1, NPHP3, NPHP4 | 10.31 |
| 15 | Infantile nephronophthisis | Enrichment | ANKS6, INVS, NEK8, NPHP3, ZNF423 | 9.50 |
| 16 | Leber plus disease | Enrichment | AHI1, BBS1, CC2D2A, CEP290, INPP5E, PDE6A, PDE6B, RP2, RPGRIP1L | 8.57 |
| 17 | Meckel syndrome, type 6 | Enrichment | CC2D2A, CEP290, TCTN2 | 6.77 |
| 18 | Ciliopathy | Enrichment | CC2D2A, RPGRIP1L, TCTN3, TMEM231 | 6.54 |
| 19 | Joubert syndrome 4 | Enrichment | NPHP1, RPGRIP1L, TMEM237 | 6.17 |
| 20 | Polydactyly | Enrichment | CC2D2A, CPLANE1, MKS1 | 4.86 |
| 21 | Nephronophthisis 4 | Enrichment | BBS9, NPHP4 | 4.51 |
| 22 | Joubert syndrome 10 | Enrichment | CC2D2A, OFD1 | 4.51 |
| 23 | Cardiac valvular dysplasia, x-linked | Enrichment | ATM, FLNA | 4.51 |
| 24 | Renal-hepatic-pancreatic dysplasia | Enrichment | NEK8, NPHP3 | 4.03 |
| 25 | Dandy-walker syndrome | Enrichment | ARMC9, CSPP1, PIBF1 | 3.96 |
| 26 | Polycystic kidney disease | Enrichment | CC2D2A, CEP290, NPHP3 | 3.89 |
| 27 | Robinow syndrome, autosomal dominant 1 | Enrichment | DVL1, DVL3 | 3.73 |
| 28 | Orofaciodigital syndrome iii | Enrichment | OFD1, TMEM231 | 3.73 |
| 29 | Focal cortical dysplasia, type ii | Enrichment | MTOR, RHEB | 3.73 |
| 30 | Bardet-biedl syndrome 14 | Enrichment | CEP290, TMEM67 | 3.73 |
| 31 | Nijmegen breakage syndrome-like disorder | Enrichment | MRE11, RAD50 | 3.73 |
| 32 | Oligohydramnios | Enrichment | CC2D2A, TMEM67 | 3.73 |
| 33 | Autosomal dominant robinow syndrome | Enrichment | DVL1, DVL3 | 3.73 |
| 34 | Isolated focal cortical dysplasia type ii | Enrichment | MTOR, RHEB | 3.73 |
| 35 | Oculomotor apraxia | Enrichment | ATM, SUFU | 3.73 |
| 36 | Robinow syndrome, autosomal recessive 1 | Enrichment | DVL1, DVL3 | 3.51 |
| 37 | Robinow syndrome, autosomal dominant 2 | Enrichment | DVL1, DVL3 | 3.51 |
| 38 | Hemimegalencephaly | Enrichment | MTOR, RHEB | 3.51 |
| 39 | Joubert syndrome with jeune asphyxiating thoracic dystrophy | Enrichment | CSPP1, KIAA0586 | 3.51 |
| 40 | Autosomal recessive robinow syndrome | Enrichment | DVL1, DVL3 | 3.34 |
| 41 | Patent ductus arteriosus | Enrichment | FLNA, INPP5E | 3.34 |
| 42 | Cone-rod dystrophy 2 | Enrichment | CEP290, PDE6B, RP2, UNC119 | 3.25 |
| 43 | Renal cell carcinoma, papillary, 1 | Enrichment | ATM, MTOR | 3.19 |
| 44 | Cakut | Enrichment | NPHP1, NPHP4, TMEM231 | 3.05 |
| 45 | Eye disease | Enrichment | AHI1, BBS9, RP2 | 3.01 |
| 46 | Cystic kidney disease | Enrichment | CC2D2A, TMEM67 | 2.96 |
| 47 | Colonic benign neoplasm | Enrichment | ATM, MRE11 | 2.96 |
| 48 | Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly | Enrichment | CC2D2A, INPP5E | 2.63 |
| 49 | Clubfoot | Enrichment | CC2D2A, INPP5E | 2.63 |
| 50 | Cone-rod dystrophy 6 | Enrichment | ARL3, PDE6B | 2.57 |
| 51 | Renal cell carcinoma, nonpapillary | Enrichment | ATM, MTOR | 2.51 |
| 52 | Kidney disease | Enrichment | CEP290, NPHP4 | 2.51 |
| 53 | Spastic ataxia | Enrichment | CEP290, MKS1, TMEM67 | 2.49 |
| 54 | Microform holoprosencephaly | Enrichment | SHH, SUFU | 2.45 |
| 55 | Hereditary breast ovarian cancer syndrome | Enrichment | ATM, MRE11, RAD50 | 2.44 |
| 56 | Cleft palate, isolated | Enrichment | FLNA, INPP5E | 2.40 |
| 57 | Holoprosencephaly 3 | Enrichment | SHH | 2.25 |
| 58 | Retinitis pigmentosa 23 | Enrichment | OFD1 | 2.25 |
| 59 | Simpson-golabi-behmel syndrome, type 2 | Enrichment | OFD1 | 2.25 |
| 60 | Otopalatodigital syndrome, type i | Enrichment | FLNA | 2.25 |
| 61 | Intestinal pseudoobstruction, neuronal, chronic idiopathic, x-linked | Enrichment | FLNA | 2.25 |
| 62 | Joubert syndrome 7 | Enrichment | RPGRIP1L | 2.25 |
| 63 | Joubert syndrome 2 | Enrichment | TMEM216 | 2.25 |
| 64 | Joubert syndrome 3 | Enrichment | AHI1 | 2.25 |
| 65 | Deafness, autosomal dominant 22 | Enrichment | MYO6 | 2.25 |
| 66 | Microphthalmia/coloboma 5 | Enrichment | SHH | 2.25 |
| 67 | Renal-hepatic-pancreatic dysplasia 2 | Enrichment | NEK8 | 2.25 |
| 68 | Immunodeficiency 13 | Enrichment | UNC119 | 2.25 |
| 69 | Short-rib thoracic dysplasia 14 with polydactyly | Enrichment | KIAA0586 | 2.25 |
| 70 | Meckel syndrome, type 3 | Enrichment | TMEM67 | 2.25 |
| 71 | Griscelli syndrome, type 1 | Enrichment | MYO5A | 2.25 |
| 72 | Retinitis pigmentosa 57 | Enrichment | PDE6G | 2.25 |
| 73 | Elejalde neuroectodermal melanolysosomal syndrome | Enrichment | MYO5A | 2.25 |
| 74 | Bardet-biedl syndrome 4 | Enrichment | BBS4 | 2.25 |
| 75 | Joubert syndrome 6 | Enrichment | TMEM67 | 2.25 |
| 76 | Joubert syndrome 8 | Enrichment | ARL13B | 2.25 |
| 77 | Nephronophthisis 9 | Enrichment | NEK8 | 2.25 |
| 78 | Microcephalic osteodysplastic primordial dwarfism, type ii | Enrichment | PCNT | 2.25 |
| 79 | Retinitis pigmentosa 98 | Enrichment | TMEM216 | 2.25 |
| 80 | Joubert syndrome 22 | Enrichment | PDE6D | 2.25 |
| 81 | Rhyns syndrome | Enrichment | TMEM67 | 2.25 |
| 82 | Retinitis pigmentosa 93 | Enrichment | CC2D2A | 2.25 |
| 83 | Joubert syndrome 35 | Enrichment | ARL3 | 2.25 |
| 84 | Joubert syndrome 32 | Enrichment | SUFU | 2.25 |
| 85 | Terminal osseous dysplasia | Enrichment | FLNA | 2.25 |
| 86 | Fg syndrome 2 | Enrichment | FLNA | 2.25 |
| 87 | Meckel syndrome, type 9 | Enrichment | B9D1 | 2.25 |
| 88 | Deafness, autosomal recessive 37 | Enrichment | MYO6 | 2.25 |
| 89 | Myopia 26, x-linked, female-limited | Enrichment | ARR3 | 2.25 |
| 90 | Joubert syndrome 9 | Enrichment | CC2D2A | 2.25 |
| 91 | Bardet-biedl syndrome 8 | Enrichment | TTC8 | 2.25 |
| 92 | Coach syndrome 2 | Enrichment | CC2D2A | 2.25 |
| 93 | Coach syndrome 3 | Enrichment | RPGRIP1L | 2.25 |
| 94 | Joubert syndrome 33 | Enrichment | PIBF1 | 2.25 |
| 95 | Meckel syndrome, type 2 | Enrichment | TMEM216 | 2.25 |
| 96 | Ataxia-telangiectasia-like disorder 1 | Enrichment | MRE11 | 2.25 |
| 97 | Otopalatodigital syndrome spectrum disorder | Enrichment | FLNA | 2.25 |
| 98 | Senior-loken syndrome 4 | Enrichment | NPHP4 | 2.25 |
| 99 | Impaired intellectual development, truncal obesity, retinal dystrophy, and micropenis syndrome | Enrichment | INPP5E | 2.25 |
| 100 | Joubert syndrome 15 | Enrichment | CEP41 | 2.25 |
| 101 | Joubert syndrome 16 | Enrichment | TMEM138 | 2.25 |
| 102 | Nephronophthisis 14 | Enrichment | ZNF423 | 2.25 |
| 103 | Nephronophthisis 15 | Enrichment | CEP164 | 2.25 |
| 104 | Bardet-biedl syndrome 7 | Enrichment | BBS7 | 2.25 |
| 105 | Meckel syndrome, type 5 | Enrichment | RPGRIP1L | 2.25 |
| 106 | Nephronophthisis 11 | Enrichment | TMEM67 | 2.25 |
| 107 | Endometrial serous adenocarcinoma | Enrichment | ATM | 2.25 |
| 108 | Peritonitis | Enrichment | TMEM67 | 2.25 |
| 109 | Meckel syndrome, type 10 | Enrichment | B9D2 | 2.25 |
| 110 | Joubert syndrome 27 | Enrichment | B9D1 | 2.25 |
| 111 | Retinitis pigmentosa 51 | Enrichment | TTC8 | 2.25 |
| 112 | Meckel syndrome, type 8 | Enrichment | TCTN2 | 2.25 |
| 113 | Retinitis pigmentosa 74 | Enrichment | BBS2 | 2.25 |
| 114 | Joubert syndrome 13 | Enrichment | TCTN1 | 2.25 |
| 115 | Retinitis pigmentosa 43 | Enrichment | PDE6A | 2.25 |
| 116 | Short-rib thoracic dysplasia 13 with or without polydactyly | Enrichment | CEP120 | 2.25 |
| 117 | Joubert syndrome 23 | Enrichment | KIAA0586 | 2.25 |
| 118 | X-linked ehlers-danlos syndrome | Enrichment | FLNA | 2.25 |
| 119 | Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies | Enrichment | RHOA | 2.25 |
| 120 | Joubert syndrome 31 | Enrichment | CEP120 | 2.25 |
| 121 | Retinitis pigmentosa 83 | Enrichment | ARL3 | 2.25 |
| 122 | Polycystic kidney disease 8 | Enrichment | NEK8 | 2.25 |
| 123 | Linear hypopigmentation and craniofacial asymmetry with acral, ocular and brain anomalies | Enrichment | RHOA | 2.25 |
| 124 | Joubert syndrome 24 | Enrichment | TCTN2 | 2.25 |
| 125 | Bardet-biedl syndrome 2 | Enrichment | BBS2 | 2.25 |
| 126 | Cephalocele | Enrichment | PIBF1 | 2.25 |
| 127 | B-cell non-hodgkin lymphoma | Enrichment | ATM | 2.25 |
| 128 | Pancreatitis | Enrichment | TMEM67 | 2.25 |
| 129 | Progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome | Enrichment | MYO6 | 2.25 |
| 130 | Autosomal dominant nonsyndromic hearing loss 22 | Enrichment | MYO6 | 2.25 |
| 131 | X-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio syndrome | Enrichment | FLNA | 2.25 |
| 132 | Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome | Enrichment | SHH | 2.25 |
| 133 | Inherited cancer-predisposing syndrome | Enrichment | ATM, MRE11, RAD50, SUFU | 2.19 |
| 134 | Breast cancer | Enrichment | ATM, MRE11, RAD50 | 2.07 |
| 135 | Nephronophthisis 1 | Enrichment | NPHP1 | 1.95 |
| 136 | Visceral neuropathy, familial, 1, autosomal recessive | Enrichment | FLNA | 1.95 |
| 137 | Spondyloepiphyseal dysplasia tarda, x-linked | Enrichment | OFD1 | 1.95 |
| 138 | Retinitis pigmentosa 2 | Enrichment | RP2 | 1.95 |
| 139 | Otopalatodigital syndrome, type ii | Enrichment | FLNA | 1.95 |
| 140 | Melnick-needles syndrome | Enrichment | FLNA | 1.95 |
| 141 | Frontometaphyseal dysplasia 1 | Enrichment | FLNA | 1.95 |
| 142 | Orofaciodigital syndrome i | Enrichment | OFD1 | 1.95 |
| 143 | Griscelli syndrome, type 3 | Enrichment | MYO5A | 1.95 |
| 144 | Solitary median maxillary central incisor | Enrichment | SHH | 1.95 |
| 145 | Joubert syndrome 14 | Enrichment | TMEM237 | 1.95 |
| 146 | Joubert syndrome 17 | Enrichment | CPLANE1 | 1.95 |
| 147 | Robinow syndrome, autosomal dominant 3 | Enrichment | DVL3 | 1.95 |
| 148 | Joubert syndrome 18 | Enrichment | TCTN3 | 1.95 |
| 149 | Meckel syndrome, type 11 | Enrichment | TMEM231 | 1.95 |
| 150 | Leber congenital amaurosis 6 | Enrichment | MKS1 | 1.95 |
| 151 | Orofaciodigital syndrome iv | Enrichment | TCTN3 | 1.95 |
| 152 | Bardet-biedl syndrome 5 | Enrichment | BBS5 | 1.95 |
| 153 | Nephronophthisis 16 | Enrichment | ANKS6 | 1.95 |
| 154 | Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities | Enrichment | KAT5 | 1.95 |
| 155 | Joubert syndrome 30 | Enrichment | ARMC9 | 1.95 |
| 156 | Cone-rod dystrophy 24 | Enrichment | UNC119 | 1.95 |
| 157 | Cebalid syndrome | Enrichment | MTOR | 1.95 |
| 158 | Seckel syndrome 7 | Enrichment | NIN | 1.95 |
| 159 | Joubert syndrome 20 | Enrichment | TMEM231 | 1.95 |
| 160 | Joubert syndrome 21 | Enrichment | CSPP1 | 1.95 |
| 161 | Spondyloepiphyseal dysplasia tarda | Enrichment | OFD1 | 1.95 |
| 162 | Bardet-biedl syndrome 13 | Enrichment | MKS1 | 1.95 |
| 163 | Congenital fibrosarcoma | Enrichment | SUFU | 1.95 |
| 164 | High grade glioma | Enrichment | ATM | 1.95 |
| 165 | Bardet-biedl syndrome 9 | Enrichment | BBS9 | 1.95 |
| 166 | T-cell prolymphocytic leukemia | Enrichment | ATM | 1.95 |
| 167 | Smith-kingsmore syndrome | Enrichment | MTOR | 1.95 |
| 168 | Joubert syndrome 28 | Enrichment | MKS1 | 1.95 |
| 169 | Intellectual developmental disorder, autosomal recessive 77 | Enrichment | CEP104 | 1.95 |
| 170 | Basal cell nevus syndrome 2 | Enrichment | SUFU | 1.95 |
| 171 | Short femur | Enrichment | INPP5E | 1.95 |
| 172 | Cerebellar malformation | Enrichment | TMEM67 | 1.95 |
| 173 | Senior-boichis syndrome | Enrichment | TMEM67 | 1.95 |
| 174 | Isolated radial hemimelia | Enrichment | SHH | 1.95 |
| 175 | Short-rib thoracic dysplasia 1 with or without polydactyly | Enrichment | CEP120, KIAA0586 | 1.84 |
| 176 | Dystonia | Enrichment | CEP104, MYO5A | 1.79 |
| 177 | Prune belly syndrome | Enrichment | FLNA | 1.78 |
| 178 | Night blindness, congenital stationary, autosomal dominant 2 | Enrichment | PDE6B | 1.78 |
| 179 | Ataxia-telangiectasia | Enrichment | ATM | 1.78 |
| 180 | Arterial tortuosity syndrome | Enrichment | FLNA | 1.78 |
| 181 | Polycythemia vera | Enrichment | ATM | 1.78 |
| 182 | Syndactyly, type iv | Enrichment | SHH | 1.78 |
| 183 | Periventricular nodular heterotopia 1 | Enrichment | FLNA | 1.78 |
| 184 | Simpson-golabi-behmel syndrome, type 1 | Enrichment | OFD1 | 1.78 |
| 185 | Retinitis pigmentosa 3 | Enrichment | RP2 | 1.78 |
| 186 | Meckel syndrome, type 7 | Enrichment | NPHP3 | 1.78 |
| 187 | Nephronophthisis 2 | Enrichment | INVS | 1.78 |
| 188 | Senior-loken syndrome 6 | Enrichment | CEP290 | 1.78 |
| 189 | Nephronophthisis 3 | Enrichment | NPHP3 | 1.78 |
| 190 | Joubert syndrome 5 | Enrichment | CEP290 | 1.78 |
| 191 | Congenital short bowel syndrome | Enrichment | FLNA | 1.78 |
| 192 | Joubert syndrome 25 | Enrichment | CEP104 | 1.78 |
| 193 | Retinitis pigmentosa 40 | Enrichment | PDE6B | 1.78 |
| 194 | Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 1 | Enrichment | ARL2 | 1.78 |
| 195 | Koolen-de vries syndrome | Enrichment | ATM | 1.78 |
| 196 | Interstitial lung disease | Enrichment | INPP5E | 1.78 |
| 197 | Hypoplastic or aplastic tibia with polydactyly | Enrichment | SHH | 1.78 |
| 198 | Frontometaphyseal dysplasia | Enrichment | FLNA | 1.78 |
| 199 | Adenocarcinoma | Enrichment | ATM | 1.78 |
| 200 | Desmoplastic/nodular medulloblastoma | Enrichment | SUFU | 1.78 |
| 201 | Cog7-congenital disorder of glycosylation | Enrichment | CEP290 | 1.78 |
| 202 | Respiratory failure | Enrichment | INPP5E | 1.78 |
| 203 | Occipital encephalocele | Enrichment | CEP290 | 1.78 |
| 204 | Late-onset nephronophthisis | Enrichment | NPHP3 | 1.78 |
| 205 | Ovarian cancer | Enrichment | ATM, MRE11, RAD50 | 1.72 |
| 206 | Congenital nervous system abnormality | Enrichment | CEP290, TMEM216, TMEM67 | 1.67 |
| 207 | Nervous system disease | Enrichment | CEP290, TMEM216, TMEM67 | 1.67 |
| 208 | Polydactyly, preaxial ii | Enrichment | SHH | 1.65 |
| 209 | Renal-hepatic-pancreatic dysplasia 1 | Enrichment | NPHP3 | 1.65 |
| 210 | Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia | Enrichment | MRE11 | 1.65 |
| 211 | Schizencephaly | Enrichment | SHH | 1.65 |
| 212 | Erythrocytosis, familial, 2 | Enrichment | CEP120 | 1.65 |
| 213 | Amyotrophy, monomelic | Enrichment | CPLANE1 | 1.65 |
| 214 | Meckel syndrome, type 4 | Enrichment | CEP290 | 1.65 |
| 215 | Mantle cell lymphoma | Enrichment | ATM | 1.65 |
| 216 | Anencephaly | Enrichment | CC2D2A | 1.65 |
| 217 | Orofaciodigital syndrome | Enrichment | OFD1 | 1.65 |
| 218 | Optic atrophy plus syndrome | Enrichment | BBS7, NPHP3 | 1.60 |
| 219 | Hereditary breast carcinoma | Enrichment | ATM, RAD50 | 1.60 |
| 220 | Albinism, oculocutaneous, type ii | Enrichment | PDE6B | 1.56 |
| 221 | Leber congenital amaurosis 10 | Enrichment | CEP290 | 1.56 |
| 222 | Glioblastoma | Enrichment | ATM | 1.56 |
| 223 | Night blindness | Enrichment | CEP290 | 1.56 |
| 224 | Basal cell nevus syndrome 1 | Enrichment | SUFU | 1.48 |
| 225 | Hemihyperplasia, isolated | Enrichment | RHOA | 1.48 |
| 226 | Epidermolysis bullosa, junctional 5b, with pyloric atresia | Enrichment | MYO6 | 1.48 |
| 227 | Renal dysplasia, cystic | Enrichment | CEP290 | 1.48 |
| 228 | Clear cell renal cell carcinoma | Enrichment | ATM | 1.48 |
| 229 | Infertility | Enrichment | NPHP4 | 1.48 |
| 230 | Overgrowth syndrome | Enrichment | MTOR | 1.41 |
| 231 | Spastic paraplegia 4, autosomal dominant | Enrichment | OFD1 | 1.36 |
| 232 | Fanconi anemia, complementation group c | Enrichment | FLNA | 1.36 |
| 233 | Immunodeficiency 47 | Enrichment | CEP290 | 1.36 |
| 234 | Cat eye syndrome | Enrichment | TMEM67 | 1.26 |
| 235 | Lynch syndrome 1 | Enrichment | ATM | 1.26 |
| 236 | Leukemia, chronic lymphocytic | Enrichment | ATM | 1.26 |
| 237 | Polymicrogyria | Enrichment | OFD1 | 1.26 |
| 238 | Primary bone dysplasia | Enrichment | INPP5E | 1.26 |
| 239 | Immune deficiency disease | Enrichment | ATM | 1.22 |
| 240 | Meningioma, familial | Enrichment | SUFU | 1.22 |
| 241 | Osteochondrodysplasia | Enrichment | INPP5E | 1.22 |
| 242 | Uterine corpus cancer | Enrichment | ATM | 1.22 |
| 243 | Familial colorectal cancer type x | Enrichment | ATM | 1.22 |
| 244 | Septooptic dysplasia | Enrichment | SHH | 1.19 |
| 245 | Meningioma | Enrichment | SUFU | 1.19 |
| 246 | Microphthalmia/coloboma 12 | Enrichment | TMEM67 | 1.15 |
| 247 | Breast-ovarian cancer, familial 1 | Enrichment | ATM | 1.15 |
| 248 | Chronic kidney disease | Enrichment | MKS1 | 1.15 |
| 249 | Osteoporosis | Enrichment | OFD1 | 1.12 |
| 250 | Medulloblastoma | Enrichment | SUFU | 1.12 |
| 251 | Periventricular nodular heterotopia | Enrichment | FLNA | 1.12 |
| 252 | Seckel syndrome | Enrichment | PCNT | 1.12 |
| 253 | Coloboma of macula | Enrichment | TMEM67 | 1.09 |
| 254 | Polydactyly, postaxial, type a1 | Enrichment | CC2D2A | 1.09 |
| 255 | Autosomal dominant polycystic kidney disease | Enrichment | NEK8 | 1.09 |
| 256 | Rare genetic intellectual disability | Enrichment | MTOR | 1.09 |
| 257 | Septopreoptic holoprosencephaly | Enrichment | SHH | 1.09 |
| 258 | Midline interhemispheric variant of holoprosencephaly | Enrichment | SHH | 1.09 |
| 259 | Hydrocephalus, congenital, 1 | Enrichment | OFD1 | 1.07 |
| 260 | Gliosarcoma | Enrichment | ATM | 1.07 |
| 261 | Lobar holoprosencephaly | Enrichment | SHH | 1.07 |
| 262 | Giant cell glioblastoma | Enrichment | ATM | 1.04 |
| 263 | Alobar holoprosencephaly | Enrichment | SHH | 1.04 |
| 264 | Patent foramen ovale | Enrichment | FLNA | 1.02 |
| 265 | Semilobar holoprosencephaly | Enrichment | SHH | 1.02 |
| 266 | Macs syndrome | Enrichment | SHH | 0.97 |
| 267 | Endometrial cancer | Enrichment | ATM | 0.95 |
| 268 | Hepatocellular carcinoma | Enrichment | RAD50 | 0.93 |
| 269 | Congenital stationary night blindness | Enrichment | PDE6B | 0.92 |
| 270 | Ear malformation | Enrichment | MYO6 | 0.90 |
| 271 | Cone dystrophy | Enrichment | BBS5 | 0.90 |
| 272 | Pancreatic cancer | Enrichment | ATM | 0.88 |
| 273 | Jeune thoracic dystrophy | Enrichment | KIAA0586 | 0.88 |
| 274 | Asphyxiating thoracic dystrophy | Enrichment | KIAA0586 | 0.84 |
| 275 | Bladder cancer | Enrichment | ATM | 0.82 |
| 276 | Prostate cancer | Enrichment | ATM | 0.82 |
| 277 | Severe covid-19 | Enrichment | CC2D2A | 0.82 |
| 278 | Differentiated thyroid carcinoma | Enrichment | PCM1 | 0.82 |
| 279 | Connective tissue disease | Enrichment | OFD1 | 0.78 |
| 280 | Usher syndrome | Enrichment | BBS1 | 0.77 |
| 281 | Non-syndromic genetic deafness | Enrichment | MYO6 | 0.74 |
| 282 | Nonsyndromic hearing loss | Enrichment | MYO6 | 0.68 |
| 283 | Gastric cancer | Enrichment | ATM | 0.67 |
| 284 | Familial thoracic aortic aneurysm and aortic dissection | Enrichment | FLNA | 0.66 |
| 285 | Rare autosomal dominant non-syndromic sensorineural deafness type dfna | Enrichment | MYO6 | 0.60 |
| 286 | Myeloma, multiple | Enrichment | ATM | 0.57 |
| 287 | Autosomal recessive non-syndromic intellectual disability | Enrichment | CEP104 | 0.56 |
| 288 | Autism | Enrichment | SHH | 0.48 |
| 289 | Primary ciliary dyskinesia | Enrichment | OFD1 | 0.46 |
| 290 | Rare genetic deafness | Enrichment | MYO6 | 0.44 |
| 291 | Colorectal cancer | Enrichment | ATM | 0.41 |
| 292 | Rare autosomal recessive non-syndromic sensorineural deafness type dfnb | Enrichment | MYO6 | 0.40 |
| 293 | Autism spectrum disorder | Enrichment | CEP104 | 0.34 |
| 294 | Microcephaly | Enrichment | CC2D2A | 0.30 |